MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
Clinical trial NCT02678923 · COMPLETED
Trial details
- NCT number
- NCT02678923
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2016-10-26
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.